Virchows Arch
Virchows Archiv
0945-6317
1432-2307
Springer-Verlag
Berlin/Heidelberg


2151131
18040713
532
10.1007/s00428-007-0532-2
Review and Perspective


MicroRNA—implications for cancer

Sassen
Stefanie

+44-1223-404426
+44-1223-404199
stefanie.sassen@cancer.org.uk

1

Miska
Eric A.

2

Caldas
Carlos

1

1
Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE UK 
2
Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK 

27
11
2007

1
2008

452
1
1
10
18
8
2007

9
10
2007

18
10
2007


© Springer-Verlag 2007

Caenorhabditis elegans
, these short regulatory RNAs have been found to be an abundant class of RNAs in plants, animals, and DNA viruses. About 3% of human genes encode for miRNAs, and up to 30% of human protein coding genes may be regulated by miRNAs. MicroRNAs play a key role in diverse biological processes, including development, cell proliferation, differentiation, and apoptosis. Accordingly, altered miRNA expression is likely to contribute to human disease, including cancer. This review will summarize the emerging knowledge of the connections between human miRNA biology and different aspects of carcinogenesis. Various techniques available to investigate miRNAs will also be discussed.

Keywords
MicroRNA
miRNA
Cancer
Pathogenesis
Development

issue-copyright-statement
© Springer-Verlag 2008




The “small RNA revolution”
50
23
87
]. The small interfering RNAs were found to repress genes by eliminating the corresponding messenger RNA transcripts, and thus, preventing protein synthesis.
Over the following years, many new small functional RNAs have been found. RNA is usually thought of as messenger RNA that serves as the template for translation of genes into proteins. In contrast, functional or non-coding RNA molecules are transcribed from a DNA sequence, but not translated into protein. The encoding DNA sequence is often referred to as an RNA gene. Functional RNA genes in the human genome include transfer RNA (tRNA), ribosomal RNA (rRNA), and various other small non-coding RNAs. Several hundred genes in our genome encode small functional RNA molecules collectively called microRNAs (miRNAs). Precursors of these miRNA molecules form structures of double-stranded RNA that can activate the RNA interference machinery. MicroRNAs downregulate gene expression either by degradation of messenger RNA through the RNA interference pathway or by inhibiting protein translation.
42
Caenorhabditis elegans
42
lin-4
70
let-7
C. elegans
lin-4
let-7
let-7
65
let-7
lin-4
let-7
Drosophila
38
40
41
38
40
41
].
38
40
41
48
71
66
75
46
68
]. This makes miRNAs one of the most abundant classes of regulatory genes in humans. MicroRNAs are now perceived as a key layer of post-transcriptional control within the networks of gene regulation.
1
1
mir
mir-1
1
43
6
28
1
Fig. 1
a
pri-miRNA
pre-miRNA
b
c
RISC
), while the complementary strand (miRNA*) is usually rapidly degraded. The miRNA incorporated into the silencing complex can bind to the target messenger RNA by base pairing, causing inhibition of protein translation and/or degradation of the target messenger RNA




10
1
30
67
1
].
lin-4
9
33
42
7
17
59
60
8
11
]. This review will focus on the connection between human miRNA biology and different aspects of carcinogenesis. Various techniques available to investigate miRNAs will also be discussed.

MicroRNAs and cancer
C. elegans
Drosophila
9
42
14
12
24
52
]. The question remained whether the altered miRNA expression observed in cancer is a cause or consequence of malignant transformation.
MicroRNAs as causal cancer genes at genomic breakpoints
13
13
mir-15
mir-16
, were located within this 30-kb deletion. They subsequently analyzed the expression of miR-15 and miR-16 in blood samples from patients with CLL. Both miRNAs were absent or downregulated in the majority (68%) of cases when compared to normal tissue or lymphocytes. This finding suggested that these two miRNAs were causally involved in the pathogenesis of chronic lymphocytic leukemia.
mir-17-92
27
63
let-7
32
].

The mir-17-92 cluster—small RNAs with oncogenic potential
mir-17-92
64
27
mir-17-92
mir-17-92
27
mir-17-92
27
mir-17-92
mir-17-92
 was the first potential non-coding oncogene, referred to as oncomir-1.
55
76
19
].
63
mir-17-92
mir-17-92
 cluster which is also induced by c-Myc does, in contrast, inhibit E2F1 expression. The authors therefore suggested a novel regulatory mechanism by which c-Myc fine-tunes gene expression by activating the transcription of target genes and by simultaneously inducing inhibitory miRNAs that reduce their translation.
mir-17-92
 cluster highlights that a distinction between oncogenic and tumor suppressor miRNAs is likely to be an oversimplification. The same miRNAs may have oncogenic or tumor suppressor activity depending on the context and the cell type they are expressed in. A single miRNA may regulate various unrelated target genes and thereby control opposing activities such as cellular proliferation and apoptosis. The ultimate function of a miRNA may depend on the tissue type they are expressed in and what target genes are present.

MicroRNAs with tumor suppressor potential
let-7
 family of miRNAs was the first group of miRNAs shown to regulate expression of a proto-oncogene, the RAS protein. RAS proteins are membrane-associated signaling proteins that regulate cell growth and differentiation. A miRNA that controls expression of these potentially oncogenic proteins would be predicted to possess tumor suppressor activity.
32
let-7
let-7
let-7
let-7
32
let-7
77
].

Global loss of miRNA expression in cancer
52
52
24
24
].
37
37
37
let-7
, is the event that promotes malignant transformation.

MicroRNAs in the p53 tumor suppressor network
16
26
26
16
].
Together, these data indicate that altered expression of miRNAs is not simply a secondary event that reflects the less differentiated state of cancer cells. In contrast, at least in some cases, miRNA expression is specifically driven by tumor suppressors and oncogenes.

MicroRNAs with a role in tumor invasion and metastasis
54
54
]. These findings, if confirmed, suggest that specific miRNAs may have a role beyond the tumor-initiating event and directly participate in tumor progression and metastasis.

Regulation of miRNAs in cancer—who regulates the regulators?
27
13
].
53
73
mir-124a
mir-127
73
] demonstrated that miR-127 was highly induced in cultured human cancer cells after treatment with demethylating drugs, suggesting that it is subject to epigenetic silencing through promoter hypermethylation.
56
44
let-7
let-7
44
56
].
81
81
].

MicroRNA profiling—implications for cancer diagnosis
52
] asked the question whether global miRNA expression profiles could classify human cancer. MicroRNA expression profiles clearly differentiated human cancers according to their developmental origin.
52
52
49
78
], which might allow analysis of paraffin-embedded samples for routine diagnostic applications.


MicroRNAs—novel therapeutic targets?
Regulatory RNAs may also have therapeutic applications by which disease-causing miRNAs could be antagonized or functional miRNAs restored. The most intuitive choice of molecules to correct altered miRNA–messenger RNA interactions are RNA oligonucleotides. These oligonucleotides need to be chemically modified to allow for stability in serum and cellular uptake. Modified antisense oligonucleotides are already being developed to utilize the intrinsic RNAi pathway for delivery of gene therapy. If the delivery problem can be overcome, then miRNA therapies may also be possible.
O
29
57
36
36
21
21
83
83
]. Together, these studies hold some promise of miRNAs as future therapeutic targets.
One limitation of antisense RNA therapies is the restricted number of cells that can be targeted. Any approach to knock down a particular miRNA with antisense oligonucleotides will only result in partial knockdown. This may represent a limitation for cancer therapies. It remains to be seen whether indirectly mediated bystander effects on cancer cells that have not been directly targeted may partly overcome this limitation. In contrast, a partial effect on function may be of therapeutic value in neurodegenerative diseases, such as Parkinson’s or Alzheimer’s disease. A partial restoration of dopamine production by antisense therapy might result in a significant clinical improvement in Parkinson patients. Similarly, a partial reduction of the disease-causing proteins in Alzheimer’s disease may lead to a clinical improvement and might be achievable by RNA based or miRNA gene therapy.

Techniques and approaches to study miRNAs
25
3
5
38
51
4
5
58
].
MicroRNA expression studies
42
84
15
60
62
82
].
52
52
].
79
31
35
61
].

Functional characterization of miRNAs
34
39
86
29
45
57
22
22
36
], which inhibit miRNA function in the adult mouse, may provide a potential research tool to study miRNA function in vivo.
88
37
].
72
80
85
88
mir-155
72
80
72
80
85
88
].

MicroRNA target sites
2
20
].
3
10
69
74
10
47
49
10
18
55
56
76
]. The fact that a single miRNA can regulate multiple targets and a particular target may be regulated by various miRNAs suggests a highly complex network of miRNA-target interactions, which is only beginning to be unraveled.


Conclusions
Over recent years, miRNAs have emerged as major players in the complex networks of gene regulation and have been implicated in various aspects of human disease. Only 5 years after the first study reported a direct involvement of miRNAs in cancer, these small RNAs have already significantly improved our understanding of carcinogenesis. In addition to protein-coding oncogenes and tumor suppressor genes, we will have to take into account miRNAs and their regulatory networks if we aim to understand the complex processes underlying malignant transformation.


References
1.
Bartel
DP


MicroRNAs: genomics, biogenesis, mechanism, and function
Cell
2004
116
281
297
10.1016/S0092-8674(04)00045-5

14744438


2.
Beitzinger M, Peters L, Zhu JY, Kremmer E, Meister G (2007) Identification of Human microRNA targets from isolated Argonaute protein complexes. RNA Biol 4(2)

3.
Bentwich
I


Prediction and validation of microRNAs and their targets
FEBS Lett
2005
579
5904
5910
10.1016/j.febslet.2005.09.040

16214134


4.
Bentwich
I

Avniel
A

Karov
Y

Aharonov
R

Gilad
S

Barad
O

Barzilai
A

Einat
P

Einav
U

Meiri
E

Sharon
E

Spector
Y

Bentwich
Z


Identification of hundreds of conserved and nonconserved human microRNAs
Nat Genet
2005
37
766
770
10.1038/ng1590

15965474


5.
Berezikov
E

Cuppen
E

Plasterk
RH


Approaches to microRNA discovery
Nat Genet
2006
38 Suppl
S2
S7
10.1038/ng1794

16736019


6.
Bernstein
E

Caudy
AA

Hammond
SM

Hannon
GJ


Role for a bidentate ribonuclease in the initiation step of RNA interference
Nature
2001
409
363
366
10.1038/35053110

11201747


7.
Bernstein
E

Kim
SY

Carmell
MA

Murchison
EP

Alcorn
H

Li
MZ

Mills
AA

Elledge
SJ

Anderson
KV

Hannon
GJ


Dicer is essential for mouse development
Nat Genet
2003
35
215
217
10.1038/ng1253

14528307


8.
Blenkiron
C

Goldstein
LD

Thorne
NP

Spiteri
I

Chin
SF

Dunning
M

Barbosa-Morais
NL

Teschendorff
A

Green
AR

Ellis
IO

Tavaré
S

Caldas
C

Miska
EA


MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype
Genome Biol
2007
8
10
R214
10.1186/gb-2007-8-10-r214

17922911


9.
Brennecke
J

Hipfner
DR

Stark
A

Russell
RB

Cohen
SM


bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila
Cell
2003
113
25
36
10.1016/S0092-8674(03)00231-9

12679032


10.
Brennecke
J

Stark
A

Russell
RB

Cohen
SM


Principles of microRNA-target recognition
PLoS Biol
2005
3
e85
10.1371/journal.pbio.0030085

15723116


11.
Caldas
C

Brenton
JD


Sizing up miRNAs as cancer genes
Nat Med
2005
11
712
714
10.1038/nm0705-712

16015356


12.
Calin
GA

Croce
CM


MicroRNA signatures in human cancers
Nat Rev Cancer
2006
6
857
866
10.1038/nrc1997

17060945


13.
Calin
GA

Dumitru
CD

Shimizu
M

Bichi
R

Zupo
S

Noch
E

Aldler
H

Rattan
S

Keating
M

Rai
K

Rassenti
L

Kipps
T

Negrini
M

Bullrich
F

Croce
CM


Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
Proc Natl Acad Sci USA
2002
99
15524
15529
10.1073/pnas.242606799

12434020


14.
Calin
GA

Sevignani
C

Dumitru
CD

Hyslop
T

Noch
E

Yendamuri
S

Shimizu
M

Rattan
S

Bullrich
F

Negrini
M

Croce
CM


Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Proc Natl Acad Sci USA
2004
101
2999
3004
10.1073/pnas.0307323101

14973191


15.
Castoldi
M

Schmidt
S

Benes
V

Noerholm
M

Kulozik
AE

Hentze
MW

Muckenthaler
MU


A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA)
RNA
2006
12
913
920
10.1261/rna.2332406

16540696


16.
Chang
TC

Wentzel
EA

Kent
OA

Ramachandran
K

Mullendore
M

Lee
KH

Feldmann
G

Yamakuchi
M

Ferlito
M

Lowenstein
CJ

Arking
DE

Beer
MA

Maitra
A

Mendell
JT


Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Mol Cell
2007
26
745
752
10.1016/j.molcel.2007.05.010

17540599


17.
Chen
CZ

Li
L

Lodish
HF

Bartel
DP


MicroRNAs modulate hematopoietic lineage differentiation
Science
2004
303
83
86
10.1126/science.1091903

14657504


18.
Cimmino
A

Calin
GA

Fabbri
M

Iorio
MV

Ferracin
M

Shimizu
M

Wojcik
SE

Aqeilan
RI

Zupo
S

Dono
M

Rassenti
L

Alder
H

Volinia
S

Liu
CG

Kipps
TJ

Negrini
M

Croce
CM


miR-15 and miR-16 induce apoptosis by targeting BCL2
Proc Natl Acad Sci USA
2005
102
13944
13949
10.1073/pnas.0506654102

16166262


19.
Dews
M

Homayouni
A

Yu
D

Murphy
D

Sevignani
C

Wentzel
E

Furth
EE

Lee
WM

Enders
GH

Mendell
JT

Thomas-Tikhonenko
A


Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
Nat Genet
2006
38
1060
1065
10.1038/ng1855

16878133


20.
Easow
G

Teleman
AA

Cohen
SM


Isolation of microRNA targets by miRNP immunopurification
RNA
2007
13
1198
1204
10.1261/rna.563707

17592038


21.
Ebert
MS

Neilson
JR

Sharp
PA


MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
Nat Methods
2007
4
721
726
10.1038/nmeth1079

17694064


22.
Fazi
F

Rosa
A

Fatica
A

Gelmetti
V

Marchis
ML

Nervi
C

Bozzoni
I


A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis
Cell
2005
123
819
831
10.1016/j.cell.2005.09.023

16325577


23.
Fire
A

Xu
S

Montgomery
MK

Kostas
SA

Driver
SE

Mello
CC


Caenorhabditis elegans

Nature
1998
391
806
811
10.1038/35888

9486653


24.
Gaur
A

Jewell
DA

Liang
Y

Ridzon
D

Moore
JH

Chen
C

Ambros
VR

Israel
MA


Characterization of microRNA expression levels and their biological correlates in human cancer cell lines
Cancer Res
2007
67
2456
2468
10.1158/0008-5472.CAN-06-2698

17363563


25.
Griffiths-Jones
S

Grocock
RJ

Dongen
S

Bateman
A

Enright
AJ


miRBase: microRNA sequences, targets and gene nomenclature
Nucleic Acids Res
2006
34
D140
D144
10.1093/nar/gkj112

16381832


26.
He
L

He
X

Lim
LP

Stanchina
E

Xuan
Z

Liang
Y

Xue
W

Zender
L

Magnus
J

Ridzon
D

Jackson
AL

Linsley
PS

Chen
C

Lowe
SW

Cleary
MA

Hannon
GJ


A microRNA component of the p53 tumour suppressor network
Nature
2007
447
1130
1134
10.1038/nature05939

17554337


27.
He
L

Thomson
JM

Hemann
MT

Hernando-Monge
E

Mu
D

Goodson
S

Powers
S

Cordon-Cardo
C

Lowe
SW

Hannon
GJ

Hammond
SM


A microRNA polycistron as a potential human oncogene
Nature
2005
435
828
833
10.1038/nature03552

15944707


28.
Hutvagner
G

McLachlan
J

Pasquinelli
AE

Balint
E

Tuschl
T

Zamore
PD


A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA
Science
2001
293
834
838
10.1126/science.1062961

11452083


29.
Hutvagner
G

Simard
MJ

Mello
CC

Zamore
PD


Sequence-specific inhibition of small RNA function
PLoS Biol
2004
2
E98
10.1371/journal.pbio.0020098

15024405


30.
Jackson
RJ

Standart
N


How do microRNAs regulate gene expression
Sci STKE
2007
2007
re1
10.1126/stke.3672007re1

17200520


31.
Jiang
J

Lee
EJ

Gusev
Y

Schmittgen
TD


Real-time expression profiling of microRNA precursors in human cancer cell lines
Nucleic Acids Res
2005
33
5394
5403
10.1093/nar/gki863

16192569


32.
Johnson
SM

Grosshans
H

Shingara
J

Byrom
M

Jarvis
R

Cheng
A

Labourier
E

Reinert
KL

Brown
D

Slack
FJ


RAS is regulated by the let-7 microRNA family
Cell
2005
120
635
647
10.1016/j.cell.2005.01.014

15766527


33.
Johnston
RJ

Hobert
O


Caenorhabditis elegans

Nature
2003
426
845
849
10.1038/nature02255

14685240


34.
Jones-Rhoades
MW

Bartel
DP

Bartel
B


MicroRNAS and their regulatory roles in plants
Annu Rev Plant Biol
2006
57
19
53
10.1146/annurev.arplant.57.032905.105218

16669754


35.
Kloosterman
WP

Wienholds
E

Bruijn
E

Kauppinen
S

Plasterk
RH


In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes
Nat Methods
2006
3
27
29
10.1038/nmeth843

16369549


36.
Krutzfeldt
J

Rajewsky
N

Braich
R

Rajeev
KG

Tuschl
T

Manoharan
M

Stoffel
M


Silencing of microRNAs in vivo with ‘antagomirs’
Nature
2005
438
685
689
10.1038/nature04303

16258535


37.
Kumar
MS

Lu
J

Mercer
KL

Golub
TR

Jacks
T


Impaired microRNA processing enhances cellular transformation and tumorigenesis
Nat Genet
2007
39
673
677
10.1038/ng2003

17401365


38.
Lagos-Quintana
M

Rauhut
R

Lendeckel
W

Tuschl
T


Identification of novel genes coding for small expressed RNAs
Science
2001
294
853
858
10.1126/science.1064921

11679670


39.
Lai
EC

Tam
B

Rubin
GM


Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs
Genes Dev
2005
19
1067
1080
10.1101/gad.1291905

15833912


40.
Lau
NC

Lim
LP

Weinstein
EG

Bartel
DP


Caenorhabditis elegans

Science
2001
294
858
862
10.1126/science.1065062

11679671


41.
Lee
RC

Ambros
V


Caenorhabditis elegans

Science
2001
294
862
864
10.1126/science.1065329

11679672


42.
Lee
RC

Feinbaum
RL

Ambros
V


C. elegans
 heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Cell
1993
75
843
854
10.1016/0092-8674(93)90529-Y

8252621


43.
Lee
Y

Ahn
C

Han
J

Choi
H

Kim
J

Yim
J

Lee
J

Provost
P

Radmark
O

Kim
S

Kim
VN


The nuclear RNase III Drosha initiates microRNA processing
Nature
2003
425
415
419
10.1038/nature01957

14508493


44.
Lee
YS

Dutta
A


The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
Genes Dev
2007
21
1025
1030
10.1101/gad.1540407

17437991


45.
Lee
YS

Kim
HK

Chung
S

Kim
KS

Dutta
A


Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation
J Biol Chem
2005
280
16635
16641
10.1074/jbc.M412247200

15722555


46.
Lewis
BP

Burge
CB

Bartel
DP


Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
Cell
2005
120
15
20
10.1016/j.cell.2004.12.035

15652477


47.
Lewis
BP

Shih
IH

Jones-Rhoades
MW

Bartel
DP

Burge
CB


Prediction of mammalian microRNA targets
Cell
2003
115
787
798
10.1016/S0092-8674(03)01018-3

14697198


48.
Lim
LP

Glasner
ME

Yekta
S

Burge
CB

Bartel
DP


Vertebrate microRNA genes
Science
2003
299
1540
10.1126/science.1080372

12624257


49.
Lim
LP

Lau
NC

Garrett-Engele
P

Grimson
A

Schelter
JM

Castle
J

Bartel
DP

Linsley
PS

Johnson
JM


Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Nature
2005
433
769
773
10.1038/nature03315

15685193


50.
Lindbo
JA

Silva-Rosales
L

Proebsting
WM

Dougherty
WG


Induction of a highly specific antiviral state in transgenic plants: implications for regulation of gene expression and virus resistance
Plant Cell
1993
5
1749
1759
10.1105/tpc.5.12.1749

12271055


51.
Lu
C

Tej
SS

Luo
S

Haudenschild
CD

Meyers
BC

Green
PJ


Elucidation of the small RNA component of the transcriptome
Science
2005
309
1567
1569
10.1126/science.1114112

16141074


52.
Lu
J

Getz
G

Miska
EA

Alvarez-Saavedra
E

Lamb
J

Peck
D

Sweet-Cordero
A

Ebert
BL

Mak
RH

Ferrando
AA

Downing
JR

Jacks
T

Horvitz
HR

Golub
TR


MicroRNA expression profiles classify human cancers
Nature
2005
435
834
838
10.1038/nature03702

15944708


53.
Lujambio
A

Ropero
S

Ballestar
E

Fraga
MF

Cerrato
C

Setien
F

Casado
S

Suarez-Gauthier
A

Sanchez-Cespedes
M

Gitt
A

Spiteri
I

Das
PP

Caldas
C

Miska
E

Esteller
M


Genetic unmasking of an epigenetically silenced microRNA in human cancer cells
Cancer Res
2007
67
1424
1429
10.1158/0008-5472.CAN-06-4218

17308079


54.
Ma
L

Teruya-Feldstein
J

Weinberg
RA


Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Nature
2007
449
682
688
10.1038/nature06174

17898713


55.
Matsubara
H

Takeuchi
T

Nishikawa
E

Yanagisawa
K

Hayashita
Y

Ebi
H

Yamada
H

Suzuki
M

Nagino
M

Nimura
Y

Osada
H

Takahashi
T


Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92
Oncogene
2007
26
6099
6105
10.1038/sj.onc.1210425

17384677


56.
Mayr
C

Hemann
MT

Bartel
DP


Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation
Science
2007
315
1576
1579
10.1126/science.1137999

17322030


57.
Meister
G

Landthaler
M

Dorsett
Y

Tuschl
T


Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing
RNA
2004
10
544
550
10.1261/rna.5235104

14970398


58.
http://microrna.sanger.ac.uk/


59.
Miska
EA


How microRNAs control cell division, differentiation and death
Curr Opin Genet Dev
2005
15
563
568
10.1016/j.gde.2005.08.005

16099643


60.
Miska
EA

Alvarez-Saavedra
E

Townsend
M

Yoshii
A

Sestan
N

Rakic
P

Constantine-Paton
M

Horvitz
HR


Microarray analysis of microRNA expression in the developing mammalian brain
Genome Biol
2004
5
R68
10.1186/gb-2004-5-9-r68

15345052


61.
Nelson
PT

Baldwin
DA

Kloosterman
WP

Kauppinen
S

Plasterk
RH

Mourelatos
Z


RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain
RNA
2006
12
187
191
10.1261/rna.2258506

16373485


62.
Nelson
PT

Baldwin
DA

Scearce
LM

Oberholtzer
JC

Tobias
JW

Mourelatos
Z


Microarray-based, high-throughput gene expression profiling of microRNAs
Nat Methods
2004
1
155
161
10.1038/nmeth717

15782179


63.
O’Donnell
KA

Wentzel
EA

Zeller
KI

Dang
CV

Mendell
JT


c-Myc-regulated microRNAs modulate E2F1 expression
Nature
2005
435
839
843
10.1038/nature03677

15944709


64.
Ota
A

Tagawa
H

Karnan
S

Tsuzuki
S

Karpas
A

Kira
S

Yoshida
Y

Seto
M


Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma
Cancer Res
2004
64
3087
3095
10.1158/0008-5472.CAN-03-3773

15126345


65.
Pasquinelli
AE

Reinhart
BJ

Slack
F

Martindale
MQ

Kuroda
MI

Maller
B

Hayward
DC

Ball
EE

Degnan
B

Muller
P

Spring
J

Srinivasan
A

Fishman
M

Finnerty
J

Corbo
J

Levine
M

Leahy
P

Davidson
E

Ruvkun
G


Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA
Nature
2000
408
86
89
10.1038/35040556

11081512


66.
Pfeffer
S

Zavolan
M

Grasser
FA

Chien
M

Russo
JJ

Ju
J

John
B

Enright
AJ

Marks
D

Sander
C

Tuschl
T


Identification of virus-encoded microRNAs
Science
2004
304
734
736
10.1126/science.1096781

15118162


67.
Pillai
RS

Bhattacharyya
SN

Filipowicz
W


Repression of protein synthesis by miRNAs: how many mechanisms
Trends Cell Biol
2007
17
118
126
10.1016/j.tcb.2006.12.007

17197185


68.
Rajewsky
N


microRNA target predictions in animals
Nat Genet
2006
38 Suppl
S8
S13
10.1038/ng1798

16736023


69.
Rajewsky
N

Socci
ND


Computational identification of microRNA targets
Dev Biol
2004
267
529
535
10.1016/j.ydbio.2003.12.003

15013811


70.
Reinhart
BJ

Slack
FJ

Basson
M

Pasquinelli
AE

Bettinger
JC

Rougvie
AE

Horvitz
HR

Ruvkun
G


Caenorhabditis elegans

Nature
2000
403
901
906
10.1038/35002607

10706289


71.
Reinhart
BJ

Weinstein
EG

Rhoades
MW

Bartel
B

Bartel
DP


MicroRNAs in plants
Genes Dev
2002
16
1616
1626
10.1101/gad.1004402

12101121


72.
Rodriguez
A

Vigorito
E

Clare
S

Warren
MV

Couttet
P

Soond
DR

Dongen
S

Grocock
RJ

Das
PP

Miska
EA

Vetrie
D

Okkenhaug
K

Enright
AJ

Dougan
G

Turner
M

Bradley
A


Requirement of bic/microRNA-155 for normal immune function
Science
2007
316
608
611
10.1126/science.1139253

17463290


73.
Saito
Y

Liang
G

Egger
G

Friedman
JM

Chuang
JC

Coetzee
GA

Jones
PA


Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Cancer Cell
2006
9
435
443
10.1016/j.ccr.2006.04.020

16766263


74.
Sethupathy
P

Megraw
M

Hatzigeorgiou
AG


A guide through present computational approaches for the identification of mammalian microRNA targets
Nat Methods
2006
3
881
886
10.1038/nmeth954

17060911


75.
Sullivan
CS

Ganem
D


MicroRNAs and viral infection
Mol Cell
2005
20
3
7
10.1016/j.molcel.2005.09.012

16209940


76.
Sylvestre
Y

Guire
V

Querido
E

Mukhopadhyay
UK

Bourdeau
V

Major
F

Ferbeyre
G

Chartrand
P


An E2F/miR-20a autoregulatory feedback loop
J Biol Chem
2007
282
2135
2143
10.1074/jbc.M608939200

17135249


77.
Takamizawa
J

Konishi
H

Yanagisawa
K

Tomida
S

Osada
H

Endoh
H

Harano
T

Yatabe
Y

Nagino
M

Nimura
Y

Mitsudomi
T

Takahashi
T


Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
Cancer Res
2004
64
3753
3756
10.1158/0008-5472.CAN-04-0637

15172979


78.
Tang
F

Hajkova
P

Barton
SC

Lao
K

Surani
MA


MicroRNA expression profiling of single whole embryonic stem cells
Nucleic Acids Res
2006
34
e9
10.1093/nar/gnj009

16434699


79.
Tang
F

Hajkova
P

Barton
SC

O’Carroll
D

Lee
C

Lao
K

Surani
MA


220-plex microRNA expression profile of a single cell
Nat Protoc
2006
1
1154
1159
10.1038/nprot.2006.161

17406397


80.
Thai
TH

Calado
DP

Casola
S

Ansel
KM

Xiao
C

Xue
Y

Murphy
A

Frendewey
D

Valenzuela
D

Kutok
JL

Schmidt-Supprian
M

Rajewsky
N

Yancopoulos
G

Rao
A

Rajewsky
K


Regulation of the germinal center response by microRNA-155
Science
2007
316
604
608
10.1126/science.1141229

17463289


81.
Thomson
JM

Newman
M

Parker
JS

Morin-Kensicki
EM

Wright
T

Hammond
SM


Extensive post-transcriptional regulation of microRNAs and its implications for cancer
Genes Dev
2006
20
2202
2207
10.1101/gad.1444406

16882971


82.
Thomson
JM

Parker
J

Perou
CM

Hammond
SM


A custom microarray platform for analysis of microRNA gene expression
Nat Methods
2004
1
47
53
10.1038/nmeth704

15782152


83.
Tsuda
N

Kawano
K

Efferson
CL

Ioannides
CG


Synthetic microRNA and double-stranded RNA targeting the 3′-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells
Int J Oncol
2005
27
1299
1306

16211225


84.
Valoczi
A

Hornyik
C

Varga
N

Burgyan
J

Kauppinen
S

Havelda
Z


Sensitive and specific detection of microRNAs by Northern blot analysis using LNA-modified oligonucleotide probes
Nucleic Acids Res
2004
32
e175
10.1093/nar/gnh171

15598818


85.
Rooij
E

Sutherland
LB

Qi
X

Richardson
JA

Hill
J

Olson
EN


Control of stress-dependent cardiac growth and gene expression by a microRNA
Science
2007
316
575
579
10.1126/science.1139089

17379774


86.
Wightman
B

Ha
I

Ruvkun
G


C. elegans

Cell
1993
75
855
862
10.1016/0092-8674(93)90530-4

8252622


87.
Zamore
PD

Tuschl
T

Sharp
PA

Bartel
DP


RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
Cell
2000
101
25
33
10.1016/S0092-8674(00)80620-0

10778853


88.
Zhao
Y

Ransom
JF

Li
A

Vedantham
V

Drehle
M

Muth
AN

Tsuchihashi
T

McManus
MT

Schwartz
RJ

Srivastava
D


Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2
Cell
2007
129
303
317
10.1016/j.cell.2007.03.030

17397913





